Substituted 1,3-dioxepins

ABSTRACT

WHEREIN R IS A LOWER ALKYL GROUP OF FROM 1 TO ABOUT 8, BOTH INCLUSIVE, CARBON ATOMS OR AN ARYL GROUP OF FROM 6 TO ABOUT 8 CARBON ATOMS INCLUSIVE. R&#39;&#39; IS HYDROGEN OR AN ALKYL GROUP OF FROM 1 TO ABOUT 8, BOTH INCLUSIVE, CARBON ATOMS, AND N IS AN INTEGER OF FROM 0 TO ABOUT 8. THE PRESENT INVENTION IS FURTHER DIRECTED TO A NOVEL PROCESS FOR THE PREPARATION OF SUCH SUBSTITUTED 1,3-DIOXEPIN COMPOUNDS WHEREIN N IS 0 BY REACTING, AT ROOM TEMPERATURES, A CORRESPONDING TRIALKYL ORTHOALKANOATE WITH CIS2-BUTENE-1,4-DIOL IN THE PRESENCE OF A NON-OXIDIZING ACID CATALYST. THE COMPOUNDS OF THE PRESENT INVENTION ARE SUITABLE FOR USE AS HERBICIDES.   O&lt;(-C1-R&#39;&#39;)(-(CH2)N-O-R)-O-CH2-CH=CH-CH2-)   THE PRESENT INVENTION IS DIRECTED TO NEW SUBSTITUTED 1,3-DIOXEPIN COMPOUNDS CORRESPONDING TO THE FORMULA:

United States Patent C "ice 3,738,997 SUBSTHTUTED 1,3-D1OXEPINS Chester E. PfiWlOSlii, Bay City, Mich, assignor to The Dow Chemical Company, Midland, Mich. No Drawing. Original application Jan. 6, 1970, Ser. No. 1,032, new Patent No. 3,652,594, dated Mar. 28, 1972. Divided and this application Sept. 9, 1971, Ser.

rm. Cl. C0711 17/00 U.S. Cl. 260-338 2 Claims ABSTRACT OF THE DISCLOSURE The present invention is directed to new substituted 1,3-dioxepin compounds corresponding to the formula:

wherein R is a lower alkyl group of from 1 to about 8, both inclusive, carbon atoms or an aryl group of from 6 to about 8 carbon atoms inclusive. R is hydrogen or an alkyl group of from 1 to about 8, both inclusive, carbon atoms, and n is an integer of from 0 to about 8. The present invention is further directed to a novel process for the preparation of such substituted 1,3-dioxepin compounds wherein n is 0 by reacting, at room temperatures, a corresponding trialkyl orthoalkanoate with cis- 2-butene-l,4-diol in the presence of a non-oxidizing acid catalyst. The compounds of the present invention are suitable for use as herbicides.

This is a division of application Ser. No. 1,032 filed Jan. 6, 1970, now U.S. Pat. No. 3,652,594, issued Mar. 28, 1972.

BACKGROUND OF THE INVENTION The present invention is directed to certain novel 1,3- dioxepin compounds corresponding to the formula:

In the above and in all succeeding formulas, R is a lower alkyl group of from 1 to about 8, both inclusive, carbon atoms, or an aryl group of from 6 to about 8, inclusive, carbon atoms. R is a hydrogen or a lower alkyl group of from 1 to about 8, both inclusive, carbon atoms, and n is an integer of from 0 to about 8.

Suitable lower alkyl groups include, for example, sat urated, monovalent aliphatic radicals, including straight and branch-chain radicals of from 1 to about 8 carbon atoms, as illustrated by, but not limited to, methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, amyl, hexyl, heptyl, octyl, iso-octyl, and the like.

The term aryl represents phenyl, or substituted phenyl groups up to 8 carbon atoms, such as tolyl, styryl, and the like.

The new compounds are liquids at room temperature and are somewhat soluble in many common organic solvents and generally of low solubility in water. The compounds are suitable for use as herbicides.

3,738,997 Patented June 12, 1973 Compounds where n is at least 1 are generally prepared by reacting a corresponding alkoxy or aryloxy acetal or ketal with cis-2-butene-l,4-diol in the presence of a nonoxidizing acid catalyst as represented below:

wherein R, R, and n are as hereinbefore defined.

Suitable alkoXy or aryloxy ketals operable in this process include, for example, l-(p-tolyloxy)-2-propanone dimethyl acetal; 3-methoxy-butyraldehyde dimethyl acetal; e-ethoxy-propionaldehyde diethyl acetal and methoxyacetaldehyde dimethyl acetal.

Any non-oxidizing acidic material of the types ordinarily employed as catalysts in organic preparations may be used in the present process. Representative operable catalysts include, for example, sulfuric acid, dichloroacetic acid, phosphoric acid, p-toluenesulfonic acid, trichloroacetic acid, dichloropropionic acid and the like.

In carrying out the preparation, the reactants are contacted with one another in any convenient manner. The reaction consumes the reactants in amounts representing essentially equimolar proportions of each and, while not critical, the use of such amounts is preferred. Usually, the reaction proceeds readily when conducted at a temperature of from about to about C., and when maintained for a period of time suficient to assume completion of the reaction. Recovery of the product from the reaction mass is achieved by employing conventional procedures. Typically, the reaction mass is cooled and neutralized with a sufiicient amount of a base, e.g., sodium carbonate, before being distilled at atmospheric or reduced pressures, whereupon the product is recovered as a liquid at room temperature.

Compounds where n is 0 are synthesized by a novel process which is disclosed as a part of the present invention. In this novel process cis-2-butene-l,4-diol is reacted with an appropriate trialkyl orthoalkanoate in the presence of a non-oxidizing acid catalyst according to the following reaction:

R OR

wherein R, R, and the non-oxidizing acid catalyst are as hereinbefore defined.

Representative trialkyl orthoalkanoates operable in this process include: trimethyl orthoformate; tri-n-butyl orthoformate; tri-n-amyl orthoformate; tri-methyl orthoacetate, and the like.

In a representative operation, the compounds are prepared by contacting the reactants with one another in any convenient manner. While the amount of the reactants utilized is not critical, a reaction whereby equimolar proportions of the reactants are employed generally results in recovery of optimum yields of the product.

Usually, the reaction proceeds at room temperature (-l825 C.), and ordinarily the reaction mass is agitated by a rocking or stirring motion throughout the reaction period. The reaction mass is maintained under such conditions for a period of time sufiicient to assure substantial completion of the reaction. Recovery of the product from the reaction mass is achieved by employing conventional procedures. Typically, the reaction mass is cooled and neutralized with a sufficient amount of base, e.g., sodium carbonate, before being distilled at atmospheric or reduced pressure, whereupon the product is recovered as a liquid at room temperature.

DESCRIPTION OF PREFERRED EMBODIMENTS The following examples illustrate the practice of the present invention and will enable those skilled in the art to practice the same but are not meant to limit the invention thereto.

Example 1 2 (methoxymethyl)-4,7-dihydro 1,3 dioxepin.60 grams (0.5 mole) of methoxy acetaldehyde dimethyl acetal, 44 grams (0.5 mole) of cis-2-butene-1,4-diol, 0.25 gram of p-toluenesulfonic acid as catalyst, and 100 milliliters of benzene were mixed. This mixture was distilled under normal atmospheric conditions until a temperature of 153 C. was observed. After the residual reaction mass was cooled and neutralized by adding a sufiicient amount of sodium carbonate, the reaction mass was further distilled at atmospheric pressure. The Z-(methoxymethyl)-4,7-dihydro-1,3-dioxepin compound was recovered from this latter distillation. This product was a liquid at room temperature and had a boiling point of 103 C. at an absolute pressure of 3.5 millimeters of Hg; its index of refraction (11 was 1.4566. The assigned structure was substantiated by infrared spectroscopy analysis.

Example 2 2-(ethoxyethy1) 4,7 dihydro 1,3 dioxepin.50 grams (0.28 mole) of B-ethoxy propionaldehyde diethyl acetal, 25 grams (0.28 mole) cis-2-butene-1,4-diol, 2 drops of concentrated sulfuric acid as catalyst, and 100 milliliters of benzene were mixed and the reaction mass distilled under normal atmospheric pressure until a temperature of 112 C. was observed. The residual reaction mass was cooled and neutralized by the addition of a sufiicient amount of sodium carbonate before further distillation. The 2-(ethoxyethyl)-4,7-dihydro-1,3-dioxepin compound was recovered from this latter distillation. This product was a liquid at room temperature, and had a boiling point of 90 C. at an absolute pressure of 4.5 millimeters of Hg. Its assigned structure was confirmed by infrared spectroscopy analysis.

Example 3 2-(2-methoxypropyl) 4,7 dihydro 1,3 dioxepin.- 50 grams (0.34 mole) of 3-meth0xy butyraldehyde dimethyl acetal, 38 grams (0.34 mole) of cis-2-butene-1,4- diol, 0.25 gram of p-toluenesulfonic acid as catalyst, and 100 milliliters of benzene were reacted and distilled at atmospheric pressure until a temperature of 109 C. was observed. The residual reaction mass was cooled and neutralized by the addition of a sufiicient amount of sodium carbonate and then further distilled. The 1,3- dioxepin product was recovered from this latter distillation as the distillate. Analysis by infrared spectroscopy methods confirmed that the product mass was substantially 2-(2-methoxypropyl)-4,7-dihydro-1,3-dioxepin having some unsaturated 1,3-dioxepin compounds in admixture therewith.

Example 4 2 methyl-Z-(p-tolyloxymethyl) 4,7 dihydro-1,3- dioxepin.Following the same general procedures set forth in Example 1, 25 grams (0.125 mole) of l-(ptolyloxy)-2-propanone dimethyl acetal, 11 grams (0.125 mole) of cis-2-butene-1,4-diol, one drop of concentrated sulfuric acid as catalyst, and 100 milliliters benzene were mixed and distilled until a temperature of 130 C. was observed. The residual reaction mass was cooled and neutralized by the addition of a sufiicient amount of sodium carbonate before further distillation. Final distillation under reduced atmospheric pressure I$ulted in the recovery of the 2-methyl-2(p-tolyloxymethyl)-4,7- dihydro-1,3-dioxepin compound as a liquid at room temperature. The recovered compound had a boiling point of 128 C. at an absolute pressure of 0.6 millimeter of Hg; its index of refraction (11 was 1.5248. The assigned structure was substantiated by infrared spectroscopy analysis.

In procedures analogous to the foregoing and in accordance with the method of the present invention, the following compounds of the present invention, where n is at least 1, are prepared:

2 butyl-Z-(butoxyheptyl) 4,7 dihydro-1,3-dioxepin (M.W. 326) by reacting together 12-butoxy-5-dodecanone dimethyl acetal and cis-2-butene-1,4-diol.

2-ethyl-2-(octyloxypentyl) 4,7 dihydro-1,3-dioxepin (M.W. 326) by reacting together 8-octyloxy-3-octanone dimethyl acetal and cis-2-butene-1,4-diol.

2-hexyl-2-(hexyloxyoctyl) 4,7 dihydro-1,3-dioxepin (M.W. 396) by reacting together 15-hexyloxy-7-pentadecanone dimethyl acetal and cis-2-butene-1,4-diol.

2-octyl-2-(ethoxyethyl) 4,7 dihydro 1,3 dioxepin (M.W. 284) by reacting together 1-ethoxy-3-undecanone dimethyl acetal and cis-2-butene-1,4-diol.

Z-(phenoxymethyl) 4,7 dihydro-1,3-dioxepin (M.W. 205) by reacting together phenoxy acetaldehyde dimethyl acetal and cis-2-butene-1,4-diol.

2 (styryloxymethyl)-4,7-dihydro-1,3-dioxepin (M.W. 232) by reacting together styryloxy acetaldehyde dimethyl acetal and cis-2-butene-1,4-diol.

2-(p-ethylphenoxy methyl) 4,7 dihydro-1,3-dioxepin (M.W. 234) by reacting together p-ethylphenoxy acetaldehyde dimethyl acetal and cis-2-butene-1,4-diol.

Example 5 2-methoxy-4,7-dihydro-1,3-dioxepin.106 grams (1.0 mole) of trimethyl orthoformate, grams (0.9 mole) of cis-2-butene-1,4-diol, and 4 drops of concentrated sulfuric acid as catalyst were contacted and the reaction mass stirred for two hours at room temperature. The reaction mass was neutralized by adding a sufficient amount of sodium carbonate and then distilled under normal atmos pheric pressure. The 2-methoxy-4,7-dihydro-1,3-dioxepin compound was recovered from the distillation as a liquid at room temperature. This product had a boiling point of 48 C. at an absolute pressure of 4.2 millimeters of Hg. The structure was confirmed by infrared spectroscopy analysis.

Example 6 2-butoxy-4,7-dihydro-1,3-dioxepin.25 grams (0.108 mole) of tri-n-butyl orthoformate, 9 grams (0.1 mole) of cis-2-butene-1,4-cliol, and one drop of concentrated sulfuric acid as catalyst were mixed and stirred for five hours at room temperature. The resulting single-phase mixture was neutralized by the addition of a sufiicient amount of sodium carbonate. Distillation under normal atmospheric pressure was carried out and the 2-butoxy- 4,7-dihydro-1,3-dioxepin compound was recovered as a liquid at room temperature. The recovered product had an index of refraction (11 of 1.4435. Its structure was confirmed by infrared spectroscopy analysis.

Example 7 2-amyloxy-4,7-dihydro-1,3-dioxepin.-70 grams (0.25 mole) of tri-n-amyl orthoformate, 22 grams (0.25 mole) of cis-2-butene-1,4-diol, and 2 drops of concentrated sulfuric acid as catalyst were mixed and stirred for 4 hours at room temperature. A single-phase mixture was ob tained which was neutralized by the addition of a sufiicient amount of sodium carbonate before distillation under normal atmospheric conditions. The 2-amyloxy- 4,7-dihydro-1,3-dioxepin compound was recovered from the distillation as a liquid at room temperature. The product had a boiling point of 79 C. at an absolute pressure of 1 m llimete o g p essure Its struc ure was confirmed with the use of infrared spectroscopy analysis methods.

Example 8 2-methoxy-2-methyl 4,7 dihydro-1,3-dioxepin.-60 grams (0.5 mole) of trimethyl orthoacetate, 42 grams (0.48 mole) of cis-2-butene-1,4-diol, and 2 drops of concentrated sulfuric acid as catalyst were mixed and stirred as in Example 3. Neutralization and distillation were also carried out as in Example 3, and the 2-methoxy-2- methyl-4,7-dihydro-1,3-dioxepin compound was recovered as a liquid at room temperature. The product had a boiling point of 44 C. at an absolute pressure of 2.8 millimeters of Hg; its index of refraction (n was 1.4520.

Its structure was also confirmed by infrared spectroscopy analysis.

In procedures analogous to the foregoing and in accordance with the method of the present invention, the following compounds of the present invention, where n is 0, are prepared:

2-ethoxy-4,7-dihydro-1,3-dioxepin (M.W. 144) by reacting together triethyl orthoformate and cis-2-butene- 1,4-diol.

2-ethoxy-2-ethyl-4,7-dihydro-1,3-dioxepin (M.W. 172) by reacting together triethyl orthopropionate and cis-2- butene-l,4-diol.

2-hexyloxy-2-propyl 4,7 dihydro-1,3-dioxepin (M.W. 242) by reacting together trihexyl orthobutyrate and cis- 2-butene-1,4-diol.

2-octyloxy-2-heptyl 4,7 dihydro-1,3-di0xepin (M.W. 32 6) by reacting together trioctyl orthooctanoate and cis- 2-butene-l,4-diol.

2-styryloxy-2-amyl 4,7 dihydro-1,3-dioxepin (M.W. 288) by reacting together tristyryl orthohexanoate and cis-2-butene-1,4-dio1.

2-tolyloxy-2-octyl 4,7 dihydro-1,3-dioxepin (M.W. 318) by reacting together tritolyl orthonouanoate and cis-2-butene-1,4-diol.

The compounds of the present invention are suitable for use as herbicides. When the product is so employed, the unmodified substance can be utilized. However, the present invention also embraces the use of the compound in a formulation. Thus, for example, the compound can be dispersed in a finely divided solid and employed therein as a dust. Also, the compound, or a solid composition comprising the compound, can be dispersed in water, typically with the aid of a wetting agent, and the resulting aqueous suspension employed as a spray. In other procedures, the compound can be employed as a constituent of organic liquid compositions, oil-in-water and water-in-oil emulsions, or water dispersions, with or without the addition of wetting, dispersing, or emulsifying agents.

In a representative operation, application of 10 pounds per acre of the'2-(ethoxyethyl)-4,7-dihydro-1,3-dioxepin, Z-(methoxymethyl) 4,7 dihydro-1,3-dioxepin, and 2- presence of an acid catalyst. (See for example Roberts and Caserio, Basic Principles of Organic Chemistry, pp. 447-448 (1965), W. A. Benjamin, Inc.) To illustrate, l-p-tolyloxy-Z-propanone dimethylacetal is prepared as follows:

H H H\ /OCHs H 2 1 CH3O-GOCH3 o 3 01130 OCH:

1-p-tolyloxy-2-propanone methyl orthoformate N om o-o -om 11000118 Starting materials of the formula R'C(0R) used in preparing the compounds wherein n is 0 are available commercially or may be synthesized. Ethyl orthoformate, for example, is prepared by reacting chloroform with sodium ethoxide, and other starting materials are similarly prepared by utilizing this method with the appropriate chemical analogs.

I claim:

1. Substituted 1,3-dioxepin compounds corresponding to the formula:

wherein R is phenyl, tolyl, p-ethylphenyl, or styryl and R is hydrogen or a loweral'kyl group of from 1 to about 8 carbon atoms, inclusive.

2. The compound of claim 1 which is 2-methyl-2-(ptolyloxymethyl)-4,7-dihydro-1,3-dioxepin.

References Cited UNITED STATES PATENTS 3,658,846 4/ 1972 Chamberlin et a1. 260-338 NORMA MILESTONE, Primary Examiner -U.S. Cl. X.R. 

